NOBILIS THERAPEUTICS, INC.
Monoclonal antibody therapeutics for immune-mediated diseases
- Sector
- Biotech
- Headquarters
- Portland, OR
- Founded
- 2015
- Latest Form D
- $500K, Feb 2018
- Total capital
- $832K
- Federal grants
- $320K
- 1 award · 2021
- Rank in peer group#450 of 502
- Private capital raised
- $513K
- 2 Form D · last Feb 2018
- 104 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 3
- 9 pending · first 2018
- Rank in peer group#28 of 502
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase I · Portable hand-held proprietary xenon inhaler for rapid reduction of opioid withdrawal symptoms$320K
- Private capital raisedForm D · SEC · 2nd filing$500K
- Private capital raisedForm D · SEC · 1st filing$13K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 502 peers
Line = medianBiotech · Molecule
- Federal grantsBelow median
- Granted patents#28 · top 6%
- Linked publications#14 · top 3%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- VLADIMIR BOGINExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 3 granted of 12- GrantedPortable Devices For Administration Of Therapeutic Gas Mixtures And Methods Of UseUSPTOUS 11,103,671
- PendingCompositions For Organ Graft Preservation And Methods Of UseUSPTOApplication 16389869
- GrantedTherapeutic Immune Modulation Using Noble Gas CompositionsUSPTOUS 10,792,305
Show all 12 patent records
- Portable Devices For Administration Of Therapeutic Gas Mixtures And Methods Of UseAug 31, 2021 · US 11,103,671Granted
- Compositions For Organ Graft Preservation And Methods Of UseOct 22, 2020 · Application 16389869Pending
- Therapeutic Immune Modulation Using Noble Gas CompositionsOct 6, 2020 · US 10,792,305Granted
- Treatment Of Anxiety Disorder And Augmentation Of Anti-anxiety Interventions By Administration Of Noble Gas Containing MixturesFeb 20, 2020 · Application 16346493Pending
- Stimulation of Regenerative Processes and Factors by Noble GasesJun 20, 2019 · Application 15847793Pending
- Noble Gas Modulation Of IL-12May 2, 2019 · Application 16224083Pending
- Treatment of Autoimmune Diseases Using Noble Gas MixturesDec 6, 2018 · Application 16037322Pending
- Treatment of Rheumatoid Arthritis Using Noble Gas MixturesJul 17, 2018 · US 10,022,397Granted
- Methods, Means And Compositions For Improving Outcomes Of Surgical Interventions And Inflammatory SequelJun 21, 2018 · Application 15847806Pending
- Treatment Of Anxiety Disorder And Augmentation Of Anti-anxiety Interventions By Administration Of Noble Gas Containing MixturesApplication PCTUS2017059387Pending
- Portable Devices For Administration Of Therapeutic Gas Mixtures And Methods Of UseApplication PCTUS2019018642Pending
- Therapeutic Immune Modulation Using Noble Gas CompositionsApplication PCTUS2016039038Pending
Recent research by its founders
- We Need to Talk About Quality of Life with Cancer Patients: Primum Non Nocere in Oncology20251 cites
- Results of International, Double-Blind, Randomized, Placebo-Controlled, Phase IIa Study of Interleukin-1 Blockade With RPH-104 (Goflikicept) in Patients With ST-Segment–Elevation Myocardial Infarction (STEMI)202422 cites
- Interleukin-1 Blockade With RPH-104 (Goflikicept) in Patients With ST-Segment Elevation Myocardial Infarction: Secondary End Points From an International, Double-Blind, Randomized, Placebo-Controlled, Phase 2a Study202413 cites
Related companies, and why
- VIVACELLE BIO INCSimilar federal contract value in Biotech · null in contracts
- FLAG THERAPEUTICS INCSimilar federal contract value in Biotech · null in contracts
- Inomagen Therapeutics, IncSimilar federal contract value in Biotech · null in contracts
- ONCONAUT THERAPEUTICS INC.Similar federal contract value in Biotech · null in contracts
- REGENE LLCSimilar federal contract value in Biotech · null in contracts
- GAVIA BIO, LLCSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .